• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

测量组织背压——皮下注射过程中的体内注射力。

Measuring tissue back-pressure--in vivo injection forces during subcutaneous injection.

作者信息

Allmendinger Andrea, Mueller Robert, Schwarb Edward, Chipperfield Mark, Huwyler Joerg, Mahler Hanns-Christian, Fischer Stefan

机构信息

Late Stage Pharmaceutical and Processing Development, Pharmaceutical Development & Supplies, Pharma Technical Development Biologics EU, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.

出版信息

Pharm Res. 2015 Jul;32(7):2229-40. doi: 10.1007/s11095-014-1611-0. Epub 2014 Dec 24.

DOI:10.1007/s11095-014-1611-0
PMID:25537343
Abstract

PURPOSE

Limited information is available on injection forces of parenterals representing the in vivo situation. Scope of the present study was to investigate the contribution of the subcutaneous (sc) tissue layer to injection forces during in vivo injection.

METHODS

Göttingen minipigs received injections of isotonic dextran solutions (1-100 mPas) into the plica inguinalis using different injection rates and volumes (0.025-0.2 mL/s and 2.5 vs. 4.5 mL).

RESULTS

The contribution of the sc back-pressure to injection forces was found to increase linearly with viscosity and injection rate ranging from 0.6 ± 0.5 N to 1.0 ± 0.4 N (1 mPas), 0.7 ± 0.2 N to 2.4 ± 1.9 N (10 mPas), and 1.8 ± 0.6 N to 4.7 ± 3.3 N (20 mPas) for injection rates of 0.025 to 0.2 mL/s, respectively. Variability increased with viscosity and injection rate. Values are average values from 10 randomized injections. A maximum of 12.9 N was reached for 20 mPas at 0.2 mL/s; 6.9 ± 0.3 N was determined for 100 mPas at 0.025 mL/s. No difference was found between injection volumes of 2.5 and 4.5 mL. The contribution of the tissue was differentiated from the contribution of the injection device and a local temperature effect. This effect was leading to warming of the (equilibrated) sample in the needle, therefore smaller injection forces than expected compensating tissue resistance to some parts.

CONCLUSIONS

When estimating injection forces representative for the in vivo situation, the contribution of the tissue has to be considered as well as local warming of the sample in the needle during injection.

摘要

目的

关于代表体内情况的注射剂注射力的信息有限。本研究的范围是调查皮下(sc)组织层在体内注射过程中对注射力的贡献。

方法

使用不同的注射速率和体积(0.025 - 0.2 mL/s以及2.5与4.5 mL),将等渗右旋糖酐溶液(1 - 100 mPas)注射到哥廷根小型猪的腹股沟皱襞中。

结果

发现皮下背压对注射力的贡献随着粘度和注射速率的增加呈线性增加,对于0.025至0.2 mL/s的注射速率,分别从0.6±0.5 N(1 mPas)增加到1.0±0.4 N,从0.7±0.2 N(10 mPas)增加到2.4±1.9 N,从1.8±0.6 N(20 mPas)增加到4.7±3.3 N。变异性随着粘度和注射速率的增加而增加。这些值是10次随机注射的平均值。在0.2 mL/s时,20 mPas的情况下达到最大12.9 N;在0.025 mL/s时,100 mPas的情况下测定为6.9±0.3 N。2.5 mL和4.5 mL的注射体积之间未发现差异。组织的贡献与注射装置的贡献以及局部温度效应区分开来。这种效应导致针内(平衡后的)样品升温,因此比预期更小的注射力补偿了部分组织阻力。

结论

在估计代表体内情况的注射力时,必须考虑组织的贡献以及注射过程中针内样品的局部升温。

相似文献

1
Measuring tissue back-pressure--in vivo injection forces during subcutaneous injection.测量组织背压——皮下注射过程中的体内注射力。
Pharm Res. 2015 Jul;32(7):2229-40. doi: 10.1007/s11095-014-1611-0. Epub 2014 Dec 24.
2
Tissue Resistance during Large-Volume Injections in Subcutaneous Tissue of Minipigs.猪皮下大体积注射中的组织阻力。
Pharm Res. 2020 Sep 4;37(10):184. doi: 10.1007/s11095-020-02906-9.
3
Influence of hypodermic needle dimensions on subcutaneous injection delivery--a pig study of injection deposition evaluated by CT scanning, histology, and backflow.皮下注射中皮下注射针尺寸的影响——通过 CT 扫描、组织学和回流评估的猪研究中的注射沉积。
Skin Res Technol. 2012 Nov;18(4):447-55. doi: 10.1111/j.1600-0846.2011.00592.x. Epub 2012 Jan 11.
4
Rheological characterization and injection forces of concentrated protein formulations: an alternative predictive model for non-Newtonian solutions.浓缩蛋白质制剂的流变学特性及注射力:一种非牛顿溶液的替代预测模型
Eur J Pharm Biopharm. 2014 Jul;87(2):318-28. doi: 10.1016/j.ejpb.2014.01.009. Epub 2014 Feb 18.
5
Intraocular pressure and injection forces during intravitreal injection into enucleated porcine eyes.眼内压和眼内注射时向眼窝内摘除的猪眼内的注射力。
Eur J Pharm Biopharm. 2021 Sep;166:87-93. doi: 10.1016/j.ejpb.2021.06.001. Epub 2021 Jun 6.
6
Understanding Subcutaneous Tissue Pressure for Engineering Injection Devices for Large-Volume Protein Delivery.了解皮下组织压力以设计用于大容量蛋白质递送的注射装置。
J Pharm Sci. 2016 Jul;105(7):2105-13. doi: 10.1016/j.xphs.2016.04.009. Epub 2016 Jun 7.
7
Transcutaneous pneumatic injection of glucose solution: a morphometric evaluation of in vivo micropig skin and tissue-mimicking phantom.
Skin Res Technol. 2017 Feb;23(1):88-96. doi: 10.1111/srt.12306. Epub 2016 Jul 19.
8
Evaluation of Loco-Regional Skin Toxicity Induced by an In Situ Forming Depot after a Single Subcutaneous Injection at Different Volumes and Flow Rates in Göttingen Minipigs.在哥廷根小型猪单次皮下注射不同体积和流速的原位形成储库后,评估局部皮肤毒性。
Int J Mol Sci. 2021 Aug 26;22(17):9250. doi: 10.3390/ijms22179250.
9
Novel cannula design improves large volume auto-injection rates for high viscosity solutions.新型套管设计提高了高粘度溶液的大容量自动注射速度。
Drug Deliv. 2022 Dec;29(1):43-51. doi: 10.1080/10717544.2021.2018069.
10
Assessment of the biological performance of the needle-free injector INJEX using the isolated porcine forelimb.使用离体猪前肢评估无针注射器INJEX的生物学性能。
Br J Dermatol. 2004 Mar;150(3):455-61. doi: 10.1111/j.1365-2133.2004.05853.x.

引用本文的文献

1
Characterization of large volume subcutaneous injections using computed tomography imaging and simultaneous pressure measurements.使用计算机断层扫描成像和同步压力测量对大容量皮下注射进行表征。
Front Drug Deliv. 2023 Jul 13;3:1223177. doi: 10.3389/fddev.2023.1223177. eCollection 2023.
2
A modeling framework for spring-driven autoinjectors with dual-chamber cartridges.一种用于带有双腔药筒的弹簧驱动自动注射器的建模框架。
Drug Deliv Transl Res. 2025 Jul 16. doi: 10.1007/s13346-025-01898-6.
3
Determining the Relationship between Delivery Parameters and Ablation Distribution for Novel Gel Ethanol Percutaneous Therapy in Ex Vivo Swine Liver.

本文引用的文献

1
Rheological characterization and injection forces of concentrated protein formulations: an alternative predictive model for non-Newtonian solutions.浓缩蛋白质制剂的流变学特性及注射力:一种非牛顿溶液的替代预测模型
Eur J Pharm Biopharm. 2014 Jul;87(2):318-28. doi: 10.1016/j.ejpb.2014.01.009. Epub 2014 Feb 18.
2
Comparative pharmacokinetics of subcutaneous trastuzumab administered via handheld syringe or proprietary single-use injection device in healthy males.健康男性经手持注射器或专用一次性注射装置皮下给予曲妥珠单抗的药代动力学比较。
Cancer Chemother Pharmacol. 2013 Nov;72(5):1079-87. doi: 10.1007/s00280-013-2273-z. Epub 2013 Sep 22.
3
确定新型凝胶乙醇经皮治疗离体猪肝时输送参数与消融分布之间的关系。
Polymers (Basel). 2024 Apr 5;16(7):997. doi: 10.3390/polym16070997.
4
Backflow reduction in local injection therapy with gelatin formulations.局部注射治疗中明胶制剂的逆流减少。
Drug Deliv. 2024 Dec;31(1):2329100. doi: 10.1080/10717544.2024.2329100. Epub 2024 Mar 22.
5
Poroelastic Characterization and Modeling of Subcutaneous Tissue Under Confined Compression.受限压缩下皮下组织的多孔弹性特征描述和建模。
Ann Biomed Eng. 2024 Jun;52(6):1638-1652. doi: 10.1007/s10439-024-03477-1. Epub 2024 Mar 12.
6
and Hydrolytic Degradation Behaviors of a Drug-Delivery System Based on the Blend of PEG and PLA Copolymers.基于聚乙二醇(PEG)和聚乳酸(PLA)共聚物共混物的药物传递系统的水解降解行为。
ACS Appl Mater Interfaces. 2023 Dec 6;15(48):55495-55509. doi: 10.1021/acsami.2c13141. Epub 2023 Nov 27.
7
Role of Modeling and Simulation in Preclinical and Clinical Long-Acting Injectable Drug Development.建模与模拟在临床前和临床长效注射用药物研发中的作用
AAPS J. 2023 Oct 17;25(6):99. doi: 10.1208/s12248-023-00864-9.
8
Toroidal-spiral particles as a CAR-T cell delivery device for solid tumor immunotherapy.环形-螺旋颗粒作为 CAR-T 细胞递送装置用于实体瘤免疫治疗。
J Control Release. 2023 Oct;362:620-630. doi: 10.1016/j.jconrel.2023.09.005. Epub 2023 Sep 12.
9
SubQ-Sim: A Subcutaneous Physiologically Based Biopharmaceutics Model. Part 1: The Injection and System Parameters.SubQ-Sim:一种皮下生理型生物药剂学模型。第 1 部分:注射和系统参数。
Pharm Res. 2023 Sep;40(9):2195-2214. doi: 10.1007/s11095-023-03567-0. Epub 2023 Aug 27.
10
Piglets' acute responses to local anesthetic injection and surgical castration: Effects of the injection method and interval between injection and castration.仔猪对局部麻醉注射和手术去势的急性反应:注射方法及注射与去势间隔时间的影响
Front Vet Sci. 2022 Sep 29;9:1009858. doi: 10.3389/fvets.2022.1009858. eCollection 2022.
Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase.
皮下注射用透明质酸酶(MabThera)和曲妥珠单抗(Herceptin)。
Br J Cancer. 2013 Sep 17;109(6):1556-61. doi: 10.1038/bjc.2013.371. Epub 2013 Sep 3.
4
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study.曲妥珠单抗治疗人表皮生长因子受体 2 阳性早期乳腺癌患者的皮下注射或静脉注射偏好(PrefHer):一项开放标签随机研究。
Lancet Oncol. 2013 Sep;14(10):962-70. doi: 10.1016/S1470-2045(13)70383-8. Epub 2013 Aug 19.
5
Comparison of subcutaneous and intravenous administration of trastuzumab: a phase I/Ib trial in healthy male volunteers and patients with HER2-positive breast cancer.曲妥珠单抗皮下和静脉给药比较:一项在健康男性志愿者和 HER2 阳性乳腺癌患者中进行的 I/ Ib 期试验。
J Clin Pharmacol. 2013 Feb;53(2):192-201. doi: 10.1177/0091270012436560.
6
Subcutaneous trastuzumab: development of a new formulation for treatment of HER2-positive early breast cancer.皮下注射曲妥珠单抗:用于治疗 HER2 阳性早期乳腺癌的新制剂的开发。
Onco Targets Ther. 2013;6:89-94. doi: 10.2147/OTT.S27733. Epub 2013 Feb 14.
7
The minipig as nonrodent species in toxicology--where are we now?小型猪作为非啮齿类动物在毒理学中的应用——我们现在在哪里?
Int J Toxicol. 2012 Nov-Dec;31(6):507-28. doi: 10.1177/1091581812462039. Epub 2012 Nov 6.
8
Characterization of protein rheology and delivery forces for combination products.组合产品的蛋白质流变学和传递力的特性描述。
J Pharm Sci. 2012 Dec;101(12):4472-80. doi: 10.1002/jps.23297. Epub 2012 Aug 31.
9
Development of a subcutaneous formulation for trastuzumab - nonclinical and clinical bridging approach to the approved intravenous dosing regimen.曲妥珠单抗皮下制剂的研发——针对已获批静脉给药方案的非临床和临床衔接方法
Arzneimittelforschung. 2012 Sep;62(9):401-9. doi: 10.1055/s-0032-1321831. Epub 2012 Aug 23.
10
Mechanistic determinants of biotherapeutics absorption following SC administration.皮下给药后生物治疗药物吸收的机制决定因素。
AAPS J. 2012 Sep;14(3):559-70. doi: 10.1208/s12248-012-9367-0. Epub 2012 May 23.